^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    AdHER2/neu DC Vaccine

    i
    Associations
    News

    Trials

    Company:
    National Cancer Institute
    Drug class:
    Immunostimulant
    Related drugs:
    Associations
    News

    Trials

    Apply
    Ad/HER2/Neu Dendritic Cell Cancer Vaccine Testing (NCT01730118)
    Phase 1
    National Cancer Institute (NCI)
    Completed
    Last update posted :
    09/10/2022
    Initiation :
    03/04/2013
    Primary completion :
    12/03/2019
    Completion :
    12/03/2019
    ALK
    |
    HR positive • HER-2 expression
    |
    AdHER2/neu DC Vaccine